FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
FDA General

Attorneys Caution Hill, FDA on Speech Restraint

Two Wiley Rein attorneys say government lawmakers and regulators should think long and hard before backing commercial speech restrictions.

Medical Devices

FDA Reclassifies Pedicle Screw Systems for Certain Uses

FDA agrees to reclassify pedicle screw systems for certain uses from Class 3 to Class 2 as requested by the Orthopedic Surgical Manufacturers Associat...

Human Drugs

Electronic Record, Signature Guidance Significant: Attorneys

Hogan Lovells attorneys discuss the significance of a new FDA draft guidance on using electronic records and signatures in clinical investigations.

Human Drugs

Latest FDA Warning Letters

FDA releases its latest batch of Warning Letters that includes Adolfo E. Kaplan and Raritan Pharmaceuticals.

Human Drugs

PharMEDium Services Recalls 2 Drugs

FDA says that PharMEDium Services is recalling certain lots of two drugs compounded using certain Hospira products that have been recalled by that com...

Human Drugs

Fera Asks for Sole Exclusivity on Generic Levothyroxine

Fera asks FDA to determine that it does not share 180-day exclusivity for levothyroxine injection with any other company and that no ANDA for the drug...

Federal Register

Comments Sought on Custom Device Exemption Reporting

Federal Register notice: FDA seeks comments on an information collection extension for Annual Reporting for Custom Device Exemption OMB Control Number...

Medical Devices

AdvaMed Amicus Brief Urges High Court Review of 510(k) Evidence

The Advanced Medical Technology Association files an amicus curiae brief urging the U.S. Supreme Court to hear the case of Ethicon v. Huskey in order ...

Medical Devices

CDRH Releases Learning Module for Corrections/Removals eSubmissions

CDRH posts a new medical device education module to its CDRH Learn program Web site Electronic Submission of 806 Reports of Corrections and Removals....

Human Drugs

Senators Seek FDA Fixes to Brand Companies Delaying Competition

A group of senators urge FDA commissioner Scott Gottlieb to address prescription drug costs by curbing abuses by drug companies to delay competition.